More positive news about fighting the coronavirus pandemic gave Wall Street a boost again on Monday. Positive economic data also secured good mood. In addition, several media reports, of which former Federal Reserve chief Janet Yellen is to become the first woman to take over the leadership of the US Treasury, raised hopes for another economic stimulus program.
Initial profit on Dow Jones Industry
temporarily melted just before the leading US index stepped up again. At the close of trading, it managed to increase 1.12 percent to 29 591.27 points, which more than compensated for the blockade on Friday. For the S&P 500 throughout the market
Although the corona pandemic is currently raging in the United States, corporate sentiment shifted significantly in November: the purchasing managers’ index compiled by the research firm Markit rose to its highest level in a good five and a half years. Analysts, however, had expected a slowdown.
The one from Biontech
According to a government representative, the corona vaccine developed in the USA could be available from December 11th in the event of urgent approval. The vaccine could be delivered to the provinces within 24 hours of receiving US FDA approval, a representative in charge of the US government’s vaccination program told CNN. Biontech papers rose 2.3 percent in New York, while Pfizer’s market-friendly stocks lost nearly half a percent.
Curevac listed shares in New York
it went up 6.7 percent after the biotech company with Wacker Chemie
With the British-Swedish pharmaceutical company Astrazeneca
“Even if the overall efficacy seems slightly lower than with mRNA vaccines, AZD1222 has a big advantage: It’s robust and easy to use, so to speak the ‘worker bees’ among the vaccines that might available against Covid-19, “explained the company from Munich Infectiologist Clemens Wendtner. Axi analyst Stephen Innes called the news from Astrazeneca a “big deal”. This would likely put the industrialized countries in a position to immunize most lung disease risk groups by spring 2021.
Bei Merck & Co.
Airlines have clearly benefited from the new Corona news: While American Airlines
despite plans for a further two per cent and a half good capital increase.
At Sensient, shareholders could look forward to a price increase of nearly two percent. The US company sells its perfume department to Symrise, a German industry colleague, for an unknown price
— By Gerold Löhle, dpa-AFX —
ISIN US2605661048 US6311011026 US78378X1072
AXC0373 2020-11-23 / 22: 31
Copyright dpa-AFX Wirtschaftsnachrichten GmbH. All rights reserved. Redistribution, republishing or permanent storage are not permitted without the express prior consent of dpa-AFX.